Ursula Windscheif

561 total citations
7 papers, 488 citations indexed

About

Ursula Windscheif is a scholar working on Physiology, Molecular Biology and Physiology. According to data from OpenAlex, Ursula Windscheif has authored 7 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 2 papers in Molecular Biology and 2 papers in Physiology. Recurrent topics in Ursula Windscheif's work include Adenosine and Purinergic Signaling (5 papers), Nitric Oxide and Endothelin Effects (2 papers) and Neonatal and fetal brain pathology (1 paper). Ursula Windscheif is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), Nitric Oxide and Endothelin Effects (2 papers) and Neonatal and fetal brain pathology (1 paper). Ursula Windscheif collaborates with scholars based in Germany, United Kingdom and United States. Ursula Windscheif's co-authors include E. Mutschler, Hans G. Bäumert, Günter Lambrecht, Thomas Friebe, Caren Hildebrandt, Ulrike Grimm, Vera Ralevic, Geoffrey Burnstock, А. У. Зиганшин and Charles H.V. Hoyle and has published in prestigious journals such as British Journal of Pharmacology, European Journal of Pharmacology and Neurobiology of Aging.

In The Last Decade

Ursula Windscheif

7 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ursula Windscheif Germany 6 383 147 137 109 83 7 488
B F King United Kingdom 14 248 0.6× 163 1.1× 239 1.7× 84 0.8× 173 2.1× 23 644
Ulrike Grimm Germany 4 226 0.6× 87 0.6× 160 1.2× 68 0.6× 96 1.2× 6 360
L. Kasakov Bulgaria 9 168 0.4× 111 0.8× 219 1.6× 110 1.0× 272 3.3× 17 577
Lorna A. Meldrum United Kingdom 9 183 0.5× 119 0.8× 304 2.2× 243 2.2× 292 3.5× 12 634
Valerie L. Saville United Kingdom 8 112 0.3× 74 0.5× 158 1.2× 139 1.3× 156 1.9× 10 369
Melanie Alexis Ruiz Spain 11 223 0.6× 63 0.4× 109 0.8× 30 0.3× 140 1.7× 18 347
S D Collins United Kingdom 7 56 0.1× 35 0.2× 148 1.1× 262 2.4× 160 1.9× 14 452
K. L. Chu United States 3 145 0.4× 42 0.3× 55 0.4× 96 0.9× 74 0.9× 3 235
R A Mueller United States 6 37 0.1× 33 0.2× 209 1.5× 59 0.5× 284 3.4× 7 601
Nadine Evers Germany 7 47 0.1× 167 1.1× 83 0.6× 196 1.8× 57 0.7× 7 404

Countries citing papers authored by Ursula Windscheif

Since Specialization
Citations

This map shows the geographic impact of Ursula Windscheif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Windscheif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Windscheif more than expected).

Fields of papers citing papers by Ursula Windscheif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Windscheif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Windscheif. The network helps show where Ursula Windscheif may publish in the future.

Co-authorship network of co-authors of Ursula Windscheif

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Windscheif. A scholar is included among the top collaborators of Ursula Windscheif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Windscheif. Ursula Windscheif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Reisberg, ‌Barry, et al.. (2000). Memantine in moderately severe to severe Alzheimer's disease (AD): Results of a placebo-controlled 6-month trial. Neurobiology of Aging. 21. 275–275. 26 indexed citations
2.
Reisberg, ‌Barry, et al.. (2000). Results of a placebo-controlled 6-month trial with memantine in moderate to severe Alzheimer's disease (AD). European Neuropsychopharmacology. 10. 363–364. 4 indexed citations
3.
Windscheif, Ursula. (1996). Purinoceptors: From History to Recent Progress. A Review. Journal of Pharmacy and Pharmacology. 48(10). 993–1011. 29 indexed citations
4.
Windscheif, Ursula, А. У. Зиганшин, Charles H.V. Hoyle, et al.. (1995). Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea‐pig taenia coli and rat duodenum. British Journal of Pharmacology. 115(8). 1509–1517. 71 indexed citations
5.
Windscheif, Ursula, et al.. (1995). Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation.. PubMed. 45(9). 994–7. 10 indexed citations
6.
Windscheif, Ursula, Vera Ralevic, Hans G. Bäumert, et al.. (1994). Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x‐purinoceptors. British Journal of Pharmacology. 113(3). 1015–1021. 74 indexed citations
7.
Lambrecht, Günter, Thomas Friebe, Ulrike Grimm, et al.. (1992). PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses. European Journal of Pharmacology. 217(2-3). 217–219. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026